Alnylam Pharmace. buy JPMorgan Chase & Co.
Start price
12.06.25
/
50%
€264.00
Target price
12.06.26
€296.26
Performance (%)
-7.54%
End price
13.06.26
€244.10
Summary
This prediction ended on 13.06.26 with a price of €244.10. With a performance of -7.54%, the BUY prediction for Alnylam Pharmace. by JPMorgan_Chase___Co_ closed slightly in the red. JPMorgan_Chase___Co_ has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 5.040% | 5.040% | -46.727% |
| iShares Core DAX® | 0,88 % | 5,63 % | 8,48 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % | 28,41 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % | 50,98 % |
| iShares S&P 500 | 1,17 % | 2,55 % | 23,60 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at JPMorgan Chase & Co. from $330.00 to $338.00. They now have an "overweight" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€406.80
13.10.25
13.10.25
€407.06
13.10.26
13.10.26
-51.50%
22:25
22:25
Stopped prediction by JPMorgan_Chase___Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€234.00
22.07.26
22.07.26
€350.68
22.07.27
22.07.27
-15.68%
22:25
22:25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€277.50
16.07.25
16.07.25
€299.70
16.07.26
16.07.26
-11.71%
17.07.26
17.07.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€270.10
24.03.25
24.03.25
€302.97
24.03.26
24.03.26
-3.00%
25.03.26
25.03.26